actonel combi d 35 mg - 1 000 mg - 880 iu film-coat. tabl./efferv. gran. sachet
theramex ireland ltd. - sodium risedronate 35 mg - eq. risedronic acid 32,5 mg (film-coated tablet); calcium carbonate 2500 mg - eq. calcium 1000 mg (effervescent granules); cholecalciferol 880 iu (effervescent granules) - film-coated tablet; effervescent granules - 35 mg - 1000 mg - 880 iu - cholecalciferol 880 iu; risedronate sodium 35 mg; calcium carbonate 2500 mg - risedronic acid, calcium and colecalciferol, sequential
actonel- risedronate sodium tablet, film coated
warner chilcott pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 150 mg - actonel is indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, actonel reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. actonel is indicated for treatment to increase bone mass in men with osteoporosis. actonel is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of ≥ 7.5 mg prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. actonel is indicated for treatment of paget’s disease of bone in men and women. - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.1) ] - inability to stand or sit upright for at least 30 minutes [see dosage
actonel risedronate sodium 75 mg film-coated tablet blister pack
theramex australia pty ltd - risedronate sodium -
actonel- risedronate sodium tablet, film coated
physicians total care, inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - actonel is indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, actonel reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. actonel is indicated for treatment to increase bone mass in men with osteoporosis. actonel is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of ≥ 7.5 mg prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. actonel is indicated for treatment of paget’s disease of bone in men and women. - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.1) ] - inability to stand or sit upright for at least 30 minutes [see dosage
actonel 5mg tablets
accord-uk ltd - risedronate sodium - oral tablet - 5mg
actonel 30 mg film-coat. tabl.
theramex ireland ltd. - sodium risedronate 30 mg - eq. risedronic acid 27,8 mg - film-coated tablet - 30 mg - risedronate sodium 30 mg - risedronic acid
actonel 5 mg film-coat. tabl.
theramex ireland ltd. - sodium risedronate 5 mg - eq. risedronic acid 4,64 mg - film-coated tablet - 5 mg - risedronate sodium 5 mg - risedronic acid
actonel 75 mg film-coat. tabl.
theramex ireland ltd. - sodium risedronate 75 mg - eq. risedronic acid 69,6 mg - film-coated tablet - 75 mg - risedronate sodium 75 mg - risedronic acid
actonel once-a-week tablet 35 mg
zuellig pharma pte. ltd. - risedronate sodium - tablet, film coated - 35 mg - risedronate sodium 35 mg
acris combi risedronate sodium 35 mg film-coated tablets and calcium carbonate 1250 mg tablets blister pack
alphapharm pty ltd - calcium carbonate,risedronate sodium -